Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Granito

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Cancers|December 24, 2021
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple ConfoundersLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
World Journal of Gastroenterology|March 29, 2005
Genetic distinctions between autoimmune hepatitis in Italy and North AmericaPaolo Muratori, Albert-J Czaja, Luigi Muratori, et al.
The American Journal of Gastroenterology|August 26, 2025
TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASEFrancesco Tovoli, Guido Zavatta, Giovanni Monaco, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance ImagingFabio Piscaglia, Massimo Iavarone, Marzia Galassi, et al.
The American Journal of Gastroenterology|June 4, 2009
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndromePaolo Muratori, Alessandro Granito, Georgios Pappas, et al.
The American Journal of Gastroenterology|October 29, 2009
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosisAlessandro Granito, Wei-Hong Yang, Luigi Muratori, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2014
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysisAnnagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2021
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trialsFrancesco Tovoli, Ingrid Garajová, Fabio Gelsomino, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 12, 2009
Sensorineural hearing loss and celiac disease: a coincidental findingUmberto Volta, Gian Gaetano Ferri, Roberto De Giorgio, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Cancers|December 24, 2021
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple ConfoundersLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
World Journal of Gastroenterology|March 29, 2005
Genetic distinctions between autoimmune hepatitis in Italy and North AmericaPaolo Muratori, Albert-J Czaja, Luigi Muratori, et al.
The American Journal of Gastroenterology|August 26, 2025
TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASEFrancesco Tovoli, Guido Zavatta, Giovanni Monaco, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance ImagingFabio Piscaglia, Massimo Iavarone, Marzia Galassi, et al.
The American Journal of Gastroenterology|June 4, 2009
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndromePaolo Muratori, Alessandro Granito, Georgios Pappas, et al.
The American Journal of Gastroenterology|October 29, 2009
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosisAlessandro Granito, Wei-Hong Yang, Luigi Muratori, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2014
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysisAnnagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2021
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trialsFrancesco Tovoli, Ingrid Garajová, Fabio Gelsomino, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 12, 2009
Sensorineural hearing loss and celiac disease: a coincidental findingUmberto Volta, Gian Gaetano Ferri, Roberto De Giorgio, et al.
Pageof 14